nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—NR0B1—Dexamethasone—multiple sclerosis	0.215	0.395	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—multiple sclerosis	0.103	0.19	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—multiple sclerosis	0.0373	0.0687	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—multiple sclerosis	0.022	0.0405	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—multiple sclerosis	0.0188	0.0346	CbGbCtD
Tretinoin—CYP3A4—Fingolimod—multiple sclerosis	0.018	0.0332	CbGbCtD
Tretinoin—CYP3A7—Dexamethasone—multiple sclerosis	0.015	0.0277	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.015	0.0277	CbGbCtD
Tretinoin—CYP2B6—Dexamethasone—multiple sclerosis	0.0143	0.0264	CbGbCtD
Tretinoin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0116	0.0214	CbGbCtD
Tretinoin—CYP3A5—Dexamethasone—multiple sclerosis	0.0113	0.0208	CbGbCtD
Tretinoin—CYP2C8—Dexamethasone—multiple sclerosis	0.0108	0.02	CbGbCtD
Tretinoin—CYP3A4—Triamcinolone—multiple sclerosis	0.00881	0.0162	CbGbCtD
Tretinoin—CYP3A4—Mitoxantrone—multiple sclerosis	0.00848	0.0156	CbGbCtD
Tretinoin—CYP2C9—Dexamethasone—multiple sclerosis	0.00756	0.0139	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—multiple sclerosis	0.00756	0.0139	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—multiple sclerosis	0.00746	0.0137	CbGbCtD
Tretinoin—CYP3A4—Prednisone—multiple sclerosis	0.00704	0.013	CbGbCtD
Tretinoin—CRABP2—pineal body—multiple sclerosis	0.00686	0.1	CbGeAlD
Tretinoin—CYP3A4—Dexamethasone—multiple sclerosis	0.0044	0.00809	CbGbCtD
Tretinoin—CRABP1—brainstem—multiple sclerosis	0.00236	0.0347	CbGeAlD
Tretinoin—CRABP1—retina—multiple sclerosis	0.00228	0.0334	CbGeAlD
Tretinoin—ALDH1A1—brainstem—multiple sclerosis	0.00178	0.0261	CbGeAlD
Tretinoin—CRABP1—medulla oblongata—multiple sclerosis	0.00165	0.0242	CbGeAlD
Tretinoin—CRABP1—midbrain—multiple sclerosis	0.00151	0.0221	CbGeAlD
Tretinoin—RARG—retina—multiple sclerosis	0.0015	0.0221	CbGeAlD
Tretinoin—CRABP2—medulla oblongata—multiple sclerosis	0.00149	0.0219	CbGeAlD
Tretinoin—CRABP1—spinal cord—multiple sclerosis	0.00147	0.0215	CbGeAlD
Tretinoin—CRABP2—spinal cord—multiple sclerosis	0.00133	0.0195	CbGeAlD
Tretinoin—RXRG—medulla oblongata—multiple sclerosis	0.0013	0.0191	CbGeAlD
Tretinoin—ALDH1A2—nervous system—multiple sclerosis	0.00128	0.0188	CbGeAlD
Tretinoin—RARRES1—brain—multiple sclerosis	0.00128	0.0187	CbGeAlD
Tretinoin—ALDH1A1—medulla oblongata—multiple sclerosis	0.00124	0.0182	CbGeAlD
Tretinoin—CRABP1—nervous system—multiple sclerosis	0.00124	0.0182	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—multiple sclerosis	0.00124	0.0181	CbGeAlD
Tretinoin—ALDH1A2—cerebellum—multiple sclerosis	0.00121	0.0177	CbGeAlD
Tretinoin—CRABP1—central nervous system—multiple sclerosis	0.00119	0.0175	CbGeAlD
Tretinoin—RXRG—midbrain—multiple sclerosis	0.00119	0.0175	CbGeAlD
Tretinoin—CRABP1—cerebellum—multiple sclerosis	0.00117	0.0171	CbGeAlD
Tretinoin—RXRG—spinal cord—multiple sclerosis	0.00116	0.017	CbGeAlD
Tretinoin—ALDH1A1—midbrain—multiple sclerosis	0.00114	0.0166	CbGeAlD
Tretinoin—CRABP2—nervous system—multiple sclerosis	0.00112	0.0164	CbGeAlD
Tretinoin—RXRA—nervous system—multiple sclerosis	0.00112	0.0163	CbGeAlD
Tretinoin—ALDH1A1—spinal cord—multiple sclerosis	0.00111	0.0162	CbGeAlD
Tretinoin—NR0B1—brain—multiple sclerosis	0.0011	0.0161	CbGeAlD
Tretinoin—CRABP2—central nervous system—multiple sclerosis	0.00108	0.0158	CbGeAlD
Tretinoin—RXRA—central nervous system—multiple sclerosis	0.00107	0.0157	CbGeAlD
Tretinoin—CRABP2—cerebellum—multiple sclerosis	0.00105	0.0155	CbGeAlD
Tretinoin—ALDH1A2—brain—multiple sclerosis	0.000981	0.0144	CbGeAlD
Tretinoin—RXRG—nervous system—multiple sclerosis	0.000979	0.0144	CbGeAlD
Tretinoin—CRABP1—brain—multiple sclerosis	0.000947	0.0139	CbGeAlD
Tretinoin—RARB—cerebellum—multiple sclerosis	0.000943	0.0138	CbGeAlD
Tretinoin—RXRG—central nervous system—multiple sclerosis	0.000943	0.0138	CbGeAlD
Tretinoin—ALDH1A1—nervous system—multiple sclerosis	0.000933	0.0137	CbGeAlD
Tretinoin—RXRB—nervous system—multiple sclerosis	0.000921	0.0135	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—multiple sclerosis	0.000899	0.0132	CbGeAlD
Tretinoin—RXRB—central nervous system—multiple sclerosis	0.000886	0.013	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—multiple sclerosis	0.000878	0.0129	CbGeAlD
Tretinoin—RXRB—cerebellum—multiple sclerosis	0.000866	0.0127	CbGeAlD
Tretinoin—CRABP2—brain—multiple sclerosis	0.000856	0.0126	CbGeAlD
Tretinoin—RXRA—brain—multiple sclerosis	0.000852	0.0125	CbGeAlD
Tretinoin—RARG—nervous system—multiple sclerosis	0.000817	0.012	CbGeAlD
Tretinoin—RARG—central nervous system—multiple sclerosis	0.000787	0.0115	CbGeAlD
Tretinoin—RARG—cerebellum—multiple sclerosis	0.000769	0.0113	CbGeAlD
Tretinoin—RARA—nervous system—multiple sclerosis	0.000768	0.0113	CbGeAlD
Tretinoin—RARB—brain—multiple sclerosis	0.000766	0.0112	CbGeAlD
Tretinoin—RXRG—brain—multiple sclerosis	0.000748	0.011	CbGeAlD
Tretinoin—RARA—central nervous system—multiple sclerosis	0.00074	0.0108	CbGeAlD
Tretinoin—RARA—cerebellum—multiple sclerosis	0.000723	0.0106	CbGeAlD
Tretinoin—ALDH1A1—brain—multiple sclerosis	0.000713	0.0105	CbGeAlD
Tretinoin—RXRB—brain—multiple sclerosis	0.000704	0.0103	CbGeAlD
Tretinoin—RARG—brain—multiple sclerosis	0.000625	0.00916	CbGeAlD
Tretinoin—RARA—brain—multiple sclerosis	0.000587	0.00861	CbGeAlD
Tretinoin—CYP2A6—cerebellum—multiple sclerosis	0.00051	0.00748	CbGeAlD
Tretinoin—CYP2A6—brain—multiple sclerosis	0.000414	0.00608	CbGeAlD
Tretinoin—CYP1A1—nervous system—multiple sclerosis	0.000281	0.00412	CbGeAlD
Tretinoin—CYP2B6—nervous system—multiple sclerosis	0.000273	0.004	CbGeAlD
Tretinoin—CYP1A1—central nervous system—multiple sclerosis	0.000271	0.00397	CbGeAlD
Tretinoin—CYP2B6—central nervous system—multiple sclerosis	0.000263	0.00385	CbGeAlD
Tretinoin—CYP2C8—brain—multiple sclerosis	0.000233	0.00341	CbGeAlD
Tretinoin—CYP1A1—brain—multiple sclerosis	0.000215	0.00315	CbGeAlD
Tretinoin—CYP2B6—brain—multiple sclerosis	0.000209	0.00306	CbGeAlD
Tretinoin—CYP3A4—nervous system—multiple sclerosis	0.000206	0.00302	CbGeAlD
Tretinoin—CYP3A4—central nervous system—multiple sclerosis	0.000199	0.00291	CbGeAlD
Tretinoin—Loss of consciousness—Dexamethasone—multiple sclerosis	7.73e-05	0.000304	CcSEcCtD
Tretinoin—Epistaxis—Methotrexate—multiple sclerosis	7.73e-05	0.000304	CcSEcCtD
Tretinoin—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.72e-05	0.000304	CcSEcCtD
Tretinoin—Paraesthesia—Prednisolone—multiple sclerosis	7.72e-05	0.000304	CcSEcCtD
Tretinoin—Tachycardia—Triamcinolone—multiple sclerosis	7.72e-05	0.000304	CcSEcCtD
Tretinoin—Mental disorder—Prednisone—multiple sclerosis	7.71e-05	0.000303	CcSEcCtD
Tretinoin—Nausea—Azathioprine—multiple sclerosis	7.7e-05	0.000303	CcSEcCtD
Tretinoin—Tachycardia—Methylprednisolone—multiple sclerosis	7.7e-05	0.000303	CcSEcCtD
Tretinoin—Skin disorder—Methylprednisolone—multiple sclerosis	7.67e-05	0.000302	CcSEcCtD
Tretinoin—Malnutrition—Prednisone—multiple sclerosis	7.66e-05	0.000301	CcSEcCtD
Tretinoin—Erythema—Prednisone—multiple sclerosis	7.66e-05	0.000301	CcSEcCtD
Tretinoin—Hyperhidrosis—Triamcinolone—multiple sclerosis	7.65e-05	0.000301	CcSEcCtD
Tretinoin—Agranulocytosis—Methotrexate—multiple sclerosis	7.64e-05	0.000301	CcSEcCtD
Tretinoin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	7.63e-05	0.0003	CcSEcCtD
Tretinoin—Convulsion—Dexamethasone—multiple sclerosis	7.62e-05	0.0003	CcSEcCtD
Tretinoin—Convulsion—Betamethasone—multiple sclerosis	7.62e-05	0.0003	CcSEcCtD
Tretinoin—Hypertension—Dexamethasone—multiple sclerosis	7.59e-05	0.000299	CcSEcCtD
Tretinoin—Hypertension—Betamethasone—multiple sclerosis	7.59e-05	0.000299	CcSEcCtD
Tretinoin—Asthenia—Mitoxantrone—multiple sclerosis	7.52e-05	0.000296	CcSEcCtD
Tretinoin—Myalgia—Dexamethasone—multiple sclerosis	7.49e-05	0.000294	CcSEcCtD
Tretinoin—Myalgia—Betamethasone—multiple sclerosis	7.49e-05	0.000294	CcSEcCtD
Tretinoin—Anxiety—Dexamethasone—multiple sclerosis	7.46e-05	0.000293	CcSEcCtD
Tretinoin—Anxiety—Betamethasone—multiple sclerosis	7.46e-05	0.000293	CcSEcCtD
Tretinoin—Discomfort—Betamethasone—multiple sclerosis	7.4e-05	0.000291	CcSEcCtD
Tretinoin—Discomfort—Dexamethasone—multiple sclerosis	7.4e-05	0.000291	CcSEcCtD
Tretinoin—Haemoglobin—Methotrexate—multiple sclerosis	7.39e-05	0.000291	CcSEcCtD
Tretinoin—Hypotension—Methylprednisolone—multiple sclerosis	7.38e-05	0.00029	CcSEcCtD
Tretinoin—Pain—Prednisolone—multiple sclerosis	7.36e-05	0.000289	CcSEcCtD
Tretinoin—Haemorrhage—Methotrexate—multiple sclerosis	7.35e-05	0.000289	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—multiple sclerosis	7.35e-05	0.000289	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—multiple sclerosis	7.3e-05	0.000287	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—multiple sclerosis	7.26e-05	0.000286	CcSEcCtD
Tretinoin—Vision blurred—Prednisone—multiple sclerosis	7.22e-05	0.000284	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—multiple sclerosis	7.21e-05	0.000284	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.21e-05	0.000283	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.19e-05	0.000283	CcSEcCtD
Tretinoin—Oedema—Betamethasone—multiple sclerosis	7.18e-05	0.000282	CcSEcCtD
Tretinoin—Anaphylactic shock—Betamethasone—multiple sclerosis	7.18e-05	0.000282	CcSEcCtD
Tretinoin—Oedema—Dexamethasone—multiple sclerosis	7.18e-05	0.000282	CcSEcCtD
Tretinoin—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.18e-05	0.000282	CcSEcCtD
Tretinoin—Diarrhoea—Mitoxantrone—multiple sclerosis	7.17e-05	0.000282	CcSEcCtD
Tretinoin—Insomnia—Triamcinolone—multiple sclerosis	7.15e-05	0.000281	CcSEcCtD
Tretinoin—Insomnia—Methylprednisolone—multiple sclerosis	7.14e-05	0.000281	CcSEcCtD
Tretinoin—Infection—Dexamethasone—multiple sclerosis	7.13e-05	0.00028	CcSEcCtD
Tretinoin—Infection—Betamethasone—multiple sclerosis	7.13e-05	0.00028	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—multiple sclerosis	7.11e-05	0.00028	CcSEcCtD
Tretinoin—Paraesthesia—Triamcinolone—multiple sclerosis	7.1e-05	0.000279	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—multiple sclerosis	7.09e-05	0.000279	CcSEcCtD
Tretinoin—Paraesthesia—Methylprednisolone—multiple sclerosis	7.09e-05	0.000279	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—multiple sclerosis	7.09e-05	0.000279	CcSEcCtD
Tretinoin—Anaemia—Prednisone—multiple sclerosis	7.08e-05	0.000278	CcSEcCtD
Tretinoin—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.07e-05	0.000527	CbGpPWpGaD
Tretinoin—Shock—Dexamethasone—multiple sclerosis	7.06e-05	0.000278	CcSEcCtD
Tretinoin—Shock—Betamethasone—multiple sclerosis	7.06e-05	0.000278	CcSEcCtD
Tretinoin—Dyspnoea—Triamcinolone—multiple sclerosis	7.05e-05	0.000277	CcSEcCtD
Tretinoin—CYP4A11—Biological oxidations—POMC—multiple sclerosis	7.05e-05	0.000525	CbGpPWpGaD
Tretinoin—Nervous system disorder—Dexamethasone—multiple sclerosis	7.04e-05	0.000277	CcSEcCtD
Tretinoin—Nervous system disorder—Betamethasone—multiple sclerosis	7.04e-05	0.000277	CcSEcCtD
Tretinoin—Agitation—Prednisone—multiple sclerosis	7.04e-05	0.000277	CcSEcCtD
Tretinoin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.04e-05	0.000524	CbGpPWpGaD
Tretinoin—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.03e-05	0.000276	CcSEcCtD
Tretinoin—Thrombocytopenia—Betamethasone—multiple sclerosis	7.03e-05	0.000276	CcSEcCtD
Tretinoin—Tachycardia—Dexamethasone—multiple sclerosis	7e-05	0.000276	CcSEcCtD
Tretinoin—Tachycardia—Betamethasone—multiple sclerosis	7e-05	0.000276	CcSEcCtD
Tretinoin—Dyspepsia—Triamcinolone—multiple sclerosis	6.96e-05	0.000274	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—multiple sclerosis	6.95e-05	0.000273	CcSEcCtD
Tretinoin—Dyspepsia—Methylprednisolone—multiple sclerosis	6.95e-05	0.000273	CcSEcCtD
Tretinoin—Hyperhidrosis—Dexamethasone—multiple sclerosis	6.94e-05	0.000273	CcSEcCtD
Tretinoin—Hyperhidrosis—Betamethasone—multiple sclerosis	6.94e-05	0.000273	CcSEcCtD
Tretinoin—RXRB—Gene Expression—PABPC1—multiple sclerosis	6.92e-05	0.000515	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PABPC1—multiple sclerosis	6.92e-05	0.000515	CbGpPWpGaD
Tretinoin—Malaise—Prednisone—multiple sclerosis	6.91e-05	0.000272	CcSEcCtD
Tretinoin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.88e-05	0.000513	CbGpPWpGaD
Tretinoin—Eye disorder—Methotrexate—multiple sclerosis	6.87e-05	0.00027	CcSEcCtD
Tretinoin—Syncope—Prednisone—multiple sclerosis	6.87e-05	0.00027	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—multiple sclerosis	6.86e-05	0.00027	CcSEcCtD
Tretinoin—Anorexia—Dexamethasone—multiple sclerosis	6.84e-05	0.000269	CcSEcCtD
Tretinoin—Anorexia—Betamethasone—multiple sclerosis	6.84e-05	0.000269	CcSEcCtD
Tretinoin—Urticaria—Prednisolone—multiple sclerosis	6.83e-05	0.000269	CcSEcCtD
Tretinoin—Fatigue—Triamcinolone—multiple sclerosis	6.82e-05	0.000268	CcSEcCtD
Tretinoin—Fatigue—Methylprednisolone—multiple sclerosis	6.8e-05	0.000268	CcSEcCtD
Tretinoin—Pain—Triamcinolone—multiple sclerosis	6.76e-05	0.000266	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—multiple sclerosis	6.73e-05	0.000265	CcSEcCtD
Tretinoin—Hypotension—Dexamethasone—multiple sclerosis	6.71e-05	0.000264	CcSEcCtD
Tretinoin—Hypotension—Betamethasone—multiple sclerosis	6.71e-05	0.000264	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.69e-05	0.000498	CbGpPWpGaD
Tretinoin—Angiopathy—Methotrexate—multiple sclerosis	6.67e-05	0.000262	CcSEcCtD
Tretinoin—Vomiting—Mitoxantrone—multiple sclerosis	6.67e-05	0.000262	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—SRM—multiple sclerosis	6.65e-05	0.000496	CbGpPWpGaD
Tretinoin—Convulsion—Prednisone—multiple sclerosis	6.64e-05	0.000261	CcSEcCtD
Tretinoin—RXRG—Gene Expression—RPL5—multiple sclerosis	6.64e-05	0.000494	CbGpPWpGaD
Tretinoin—Hypertension—Prednisone—multiple sclerosis	6.61e-05	0.00026	CcSEcCtD
Tretinoin—Rash—Mitoxantrone—multiple sclerosis	6.61e-05	0.00026	CcSEcCtD
Tretinoin—Dermatitis—Mitoxantrone—multiple sclerosis	6.6e-05	0.00026	CcSEcCtD
Tretinoin—Chills—Methotrexate—multiple sclerosis	6.6e-05	0.000259	CcSEcCtD
Tretinoin—Headache—Mitoxantrone—multiple sclerosis	6.57e-05	0.000258	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.54e-05	0.000257	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.54e-05	0.000257	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.52e-05	0.000486	CbGpPWpGaD
Tretinoin—Myalgia—Prednisone—multiple sclerosis	6.52e-05	0.000256	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—multiple sclerosis	6.52e-05	0.000256	CcSEcCtD
Tretinoin—Feeling abnormal—Triamcinolone—multiple sclerosis	6.52e-05	0.000256	CcSEcCtD
Tretinoin—RARB—Gene Expression—RPL5—multiple sclerosis	6.51e-05	0.000485	CbGpPWpGaD
Tretinoin—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.5e-05	0.000256	CcSEcCtD
Tretinoin—Anxiety—Prednisone—multiple sclerosis	6.5e-05	0.000256	CcSEcCtD
Tretinoin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.5e-05	0.000484	CbGpPWpGaD
Tretinoin—Alopecia—Methotrexate—multiple sclerosis	6.5e-05	0.000256	CcSEcCtD
Tretinoin—Insomnia—Dexamethasone—multiple sclerosis	6.49e-05	0.000255	CcSEcCtD
Tretinoin—Insomnia—Betamethasone—multiple sclerosis	6.49e-05	0.000255	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.48e-05	0.000255	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.47e-05	0.000482	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.47e-05	0.000482	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.45e-05	0.000254	CcSEcCtD
Tretinoin—Paraesthesia—Dexamethasone—multiple sclerosis	6.44e-05	0.000254	CcSEcCtD
Tretinoin—Paraesthesia—Betamethasone—multiple sclerosis	6.44e-05	0.000254	CcSEcCtD
Tretinoin—Discomfort—Prednisone—multiple sclerosis	6.44e-05	0.000253	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—multiple sclerosis	6.44e-05	0.000253	CcSEcCtD
Tretinoin—Erythema—Methotrexate—multiple sclerosis	6.4e-05	0.000252	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—multiple sclerosis	6.4e-05	0.000252	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisolone—multiple sclerosis	6.34e-05	0.000249	CcSEcCtD
Tretinoin—Dyspepsia—Betamethasone—multiple sclerosis	6.32e-05	0.000249	CcSEcCtD
Tretinoin—Dyspepsia—Dexamethasone—multiple sclerosis	6.32e-05	0.000249	CcSEcCtD
Tretinoin—Urticaria—Triamcinolone—multiple sclerosis	6.28e-05	0.000247	CcSEcCtD
Tretinoin—Urticaria—Methylprednisolone—multiple sclerosis	6.27e-05	0.000247	CcSEcCtD
Tretinoin—Body temperature increased—Triamcinolone—multiple sclerosis	6.25e-05	0.000246	CcSEcCtD
Tretinoin—Oedema—Prednisone—multiple sclerosis	6.25e-05	0.000246	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—multiple sclerosis	6.25e-05	0.000246	CcSEcCtD
Tretinoin—Abdominal pain—Methylprednisolone—multiple sclerosis	6.24e-05	0.000245	CcSEcCtD
Tretinoin—Decreased appetite—Betamethasone—multiple sclerosis	6.24e-05	0.000245	CcSEcCtD
Tretinoin—Decreased appetite—Dexamethasone—multiple sclerosis	6.24e-05	0.000245	CcSEcCtD
Tretinoin—RXRB—Gene Expression—RPL5—multiple sclerosis	6.24e-05	0.000465	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—RPL5—multiple sclerosis	6.24e-05	0.000465	CbGpPWpGaD
Tretinoin—Nausea—Mitoxantrone—multiple sclerosis	6.23e-05	0.000245	CcSEcCtD
Tretinoin—Infection—Prednisone—multiple sclerosis	6.21e-05	0.000244	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—IL6—multiple sclerosis	6.2e-05	0.000462	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.2e-05	0.000244	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.2e-05	0.000244	CcSEcCtD
Tretinoin—Back pain—Methotrexate—multiple sclerosis	6.19e-05	0.000244	CcSEcCtD
Tretinoin—Fatigue—Betamethasone—multiple sclerosis	6.19e-05	0.000243	CcSEcCtD
Tretinoin—Fatigue—Dexamethasone—multiple sclerosis	6.19e-05	0.000243	CcSEcCtD
Tretinoin—CYP2C18—Biological oxidations—POMC—multiple sclerosis	6.16e-05	0.000459	CbGpPWpGaD
Tretinoin—Shock—Prednisone—multiple sclerosis	6.15e-05	0.000242	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—PRNP—multiple sclerosis	6.14e-05	0.000457	CbGpPWpGaD
Tretinoin—Pain—Dexamethasone—multiple sclerosis	6.14e-05	0.000241	CcSEcCtD
Tretinoin—Pain—Betamethasone—multiple sclerosis	6.14e-05	0.000241	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	6.13e-05	0.000457	CbGpPWpGaD
Tretinoin—Nervous system disorder—Prednisone—multiple sclerosis	6.13e-05	0.000241	CcSEcCtD
Tretinoin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.12e-05	0.000456	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.12e-05	0.000456	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—BCHE—multiple sclerosis	6.11e-05	0.000456	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—BCHE—multiple sclerosis	6.11e-05	0.000456	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—BCHE—multiple sclerosis	6.11e-05	0.000456	CbGpPWpGaD
Tretinoin—Tachycardia—Prednisone—multiple sclerosis	6.1e-05	0.00024	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—multiple sclerosis	6.07e-05	0.000239	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—multiple sclerosis	6.04e-05	0.000238	CcSEcCtD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.04e-05	0.00045	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.04e-05	0.00045	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SRM—multiple sclerosis	6.03e-05	0.00045	CbGpPWpGaD
Tretinoin—Vision blurred—Methotrexate—multiple sclerosis	6.03e-05	0.000237	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.96e-05	0.000444	CbGpPWpGaD
Tretinoin—Anorexia—Prednisone—multiple sclerosis	5.96e-05	0.000234	CcSEcCtD
Tretinoin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.96e-05	0.000444	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.95e-05	0.000443	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.94e-05	0.000443	CbGpPWpGaD
Tretinoin—Ill-defined disorder—Methotrexate—multiple sclerosis	5.94e-05	0.000234	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.93e-05	0.000442	CbGpPWpGaD
Tretinoin—Anaemia—Methotrexate—multiple sclerosis	5.92e-05	0.000233	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—multiple sclerosis	5.91e-05	0.000233	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—multiple sclerosis	5.91e-05	0.000233	CcSEcCtD
Tretinoin—RXRA—Gene Expression—HNRNPA1—multiple sclerosis	5.88e-05	0.000438	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—U2AF2—multiple sclerosis	5.88e-05	0.000438	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.87e-05	0.000231	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.87e-05	0.000231	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.85e-05	0.000436	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—IL6—multiple sclerosis	5.83e-05	0.000435	CbGpPWpGaD
Tretinoin—Hypersensitivity—Triamcinolone—multiple sclerosis	5.83e-05	0.000229	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.82e-05	0.000434	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.81e-05	0.000229	CcSEcCtD
Tretinoin—Malaise—Methotrexate—multiple sclerosis	5.77e-05	0.000227	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	5.73e-05	0.000427	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—PGR—multiple sclerosis	5.71e-05	0.000426	CbGpPWpGaD
Tretinoin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.7e-05	0.000425	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.7e-05	0.000425	CbGpPWpGaD
Tretinoin—Urticaria—Dexamethasone—multiple sclerosis	5.7e-05	0.000224	CcSEcCtD
Tretinoin—Urticaria—Betamethasone—multiple sclerosis	5.7e-05	0.000224	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.69e-05	0.000224	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.69e-05	0.000424	CbGpPWpGaD
Tretinoin—Dizziness—Prednisolone—multiple sclerosis	5.69e-05	0.000224	CcSEcCtD
Tretinoin—Asthenia—Triamcinolone—multiple sclerosis	5.68e-05	0.000223	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—multiple sclerosis	5.67e-05	0.000223	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—multiple sclerosis	5.67e-05	0.000223	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—multiple sclerosis	5.67e-05	0.000223	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—multiple sclerosis	5.67e-05	0.000223	CcSEcCtD
Tretinoin—Asthenia—Methylprednisolone—multiple sclerosis	5.66e-05	0.000223	CcSEcCtD
Tretinoin—Insomnia—Prednisone—multiple sclerosis	5.65e-05	0.000222	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—multiple sclerosis	5.61e-05	0.000221	CcSEcCtD
Tretinoin—Pruritus—Triamcinolone—multiple sclerosis	5.6e-05	0.00022	CcSEcCtD
Tretinoin—RXRA—Biological oxidations—POMC—multiple sclerosis	5.59e-05	0.000417	CbGpPWpGaD
Tretinoin—Cough—Methotrexate—multiple sclerosis	5.59e-05	0.00022	CcSEcCtD
Tretinoin—Pruritus—Methylprednisolone—multiple sclerosis	5.58e-05	0.00022	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.58e-05	0.000416	CbGpPWpGaD
Tretinoin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.58e-05	0.000415	CbGpPWpGaD
Tretinoin—Convulsion—Methotrexate—multiple sclerosis	5.55e-05	0.000218	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.54e-05	0.000413	CbGpPWpGaD
Tretinoin—Dyspepsia—Prednisone—multiple sclerosis	5.5e-05	0.000216	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—multiple sclerosis	5.45e-05	0.000214	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—multiple sclerosis	5.45e-05	0.000214	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—multiple sclerosis	5.45e-05	0.000214	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—multiple sclerosis	5.43e-05	0.000214	CcSEcCtD
Tretinoin—Rash—Prednisolone—multiple sclerosis	5.42e-05	0.000213	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—multiple sclerosis	5.42e-05	0.000213	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.41e-05	0.000213	CcSEcCtD
Tretinoin—Diarrhoea—Methylprednisolone—multiple sclerosis	5.4e-05	0.000212	CcSEcCtD
Tretinoin—Fatigue—Prednisone—multiple sclerosis	5.39e-05	0.000212	CcSEcCtD
Tretinoin—Headache—Prednisolone—multiple sclerosis	5.39e-05	0.000212	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—multiple sclerosis	5.38e-05	0.000212	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—CYP24A1—multiple sclerosis	5.36e-05	0.000399	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP27B1—multiple sclerosis	5.36e-05	0.000399	CbGpPWpGaD
Tretinoin—Constipation—Prednisone—multiple sclerosis	5.35e-05	0.00021	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—PGR—multiple sclerosis	5.32e-05	0.000396	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.31e-05	0.000396	CbGpPWpGaD
Tretinoin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.27e-05	0.000393	CbGpPWpGaD
Tretinoin—Confusional state—Methotrexate—multiple sclerosis	5.27e-05	0.000207	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.24e-05	0.00039	CbGpPWpGaD
Tretinoin—Dizziness—Triamcinolone—multiple sclerosis	5.23e-05	0.000206	CcSEcCtD
Tretinoin—RXRG—Gene Expression—PGR—multiple sclerosis	5.22e-05	0.000389	CbGpPWpGaD
Tretinoin—Anaphylactic shock—Methotrexate—multiple sclerosis	5.22e-05	0.000205	CcSEcCtD
Tretinoin—Dizziness—Methylprednisolone—multiple sclerosis	5.22e-05	0.000205	CcSEcCtD
Tretinoin—Infection—Methotrexate—multiple sclerosis	5.19e-05	0.000204	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.17e-05	0.000385	CbGpPWpGaD
Tretinoin—Feeling abnormal—Prednisone—multiple sclerosis	5.15e-05	0.000203	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—multiple sclerosis	5.15e-05	0.000203	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—multiple sclerosis	5.15e-05	0.000203	CcSEcCtD
Tretinoin—RARB—Gene Expression—PGR—multiple sclerosis	5.12e-05	0.000382	CbGpPWpGaD
Tretinoin—Nervous system disorder—Methotrexate—multiple sclerosis	5.12e-05	0.000202	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—multiple sclerosis	5.11e-05	0.000201	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—multiple sclerosis	5.11e-05	0.000201	CcSEcCtD
Tretinoin—Nausea—Prednisolone—multiple sclerosis	5.11e-05	0.000201	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—multiple sclerosis	5.08e-05	0.0002	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—multiple sclerosis	5.08e-05	0.0002	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—multiple sclerosis	5.07e-05	0.0002	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—multiple sclerosis	5.05e-05	0.000199	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—multiple sclerosis	5.03e-05	0.000198	CcSEcCtD
Tretinoin—Vomiting—Methylprednisolone—multiple sclerosis	5.02e-05	0.000197	CcSEcCtD
Tretinoin—Rash—Triamcinolone—multiple sclerosis	4.99e-05	0.000196	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—multiple sclerosis	4.98e-05	0.000196	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—multiple sclerosis	4.98e-05	0.000196	CcSEcCtD
Tretinoin—Rash—Methylprednisolone—multiple sclerosis	4.98e-05	0.000196	CcSEcCtD
Tretinoin—Dermatitis—Methylprednisolone—multiple sclerosis	4.97e-05	0.000196	CcSEcCtD
Tretinoin—Urticaria—Prednisone—multiple sclerosis	4.97e-05	0.000195	CcSEcCtD
Tretinoin—Headache—Triamcinolone—multiple sclerosis	4.96e-05	0.000195	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—VDR—multiple sclerosis	4.95e-05	0.000369	CbGpPWpGaD
Tretinoin—Headache—Methylprednisolone—multiple sclerosis	4.94e-05	0.000194	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—multiple sclerosis	4.94e-05	0.000194	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—multiple sclerosis	4.94e-05	0.000194	CcSEcCtD
Tretinoin—RXRB—Gene Expression—PGR—multiple sclerosis	4.91e-05	0.000366	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PGR—multiple sclerosis	4.91e-05	0.000366	CbGpPWpGaD
Tretinoin—Diarrhoea—Betamethasone—multiple sclerosis	4.91e-05	0.000193	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—multiple sclerosis	4.91e-05	0.000193	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—GPC5—multiple sclerosis	4.9e-05	0.000365	CbGpPWpGaD
Tretinoin—Hypotension—Methotrexate—multiple sclerosis	4.88e-05	0.000192	CcSEcCtD
Tretinoin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.85e-05	0.000361	CbGpPWpGaD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.83e-05	0.00036	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.78e-05	0.000356	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.78e-05	0.000356	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PTPRC—multiple sclerosis	4.77e-05	0.000356	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.76e-05	0.000187	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—multiple sclerosis	4.75e-05	0.000187	CcSEcCtD
Tretinoin—Dizziness—Betamethasone—multiple sclerosis	4.75e-05	0.000187	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—multiple sclerosis	4.72e-05	0.000186	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—multiple sclerosis	4.7e-05	0.000185	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—multiple sclerosis	4.69e-05	0.000185	CcSEcCtD
Tretinoin—Nausea—Methylprednisolone—multiple sclerosis	4.69e-05	0.000184	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	4.69e-05	0.000349	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	4.69e-05	0.000349	CbGpPWpGaD
Tretinoin—Dyspnoea—Methotrexate—multiple sclerosis	4.66e-05	0.000183	CcSEcCtD
Tretinoin—RXRA—Gene Expression—ZFP36L1—multiple sclerosis	4.65e-05	0.000346	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.65e-05	0.000346	CbGpPWpGaD
Tretinoin—Somnolence—Methotrexate—multiple sclerosis	4.64e-05	0.000183	CcSEcCtD
Tretinoin—CYP4A11—NRF2 pathway—TGFB1—multiple sclerosis	4.64e-05	0.000345	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.63e-05	0.000345	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisone—multiple sclerosis	4.61e-05	0.000181	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—multiple sclerosis	4.6e-05	0.000181	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—multiple sclerosis	4.56e-05	0.000179	CcSEcCtD
Tretinoin—Vomiting—Betamethasone—multiple sclerosis	4.56e-05	0.000179	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.54e-05	0.000339	CbGpPWpGaD
Tretinoin—Decreased appetite—Methotrexate—multiple sclerosis	4.54e-05	0.000179	CcSEcCtD
Tretinoin—Rash—Dexamethasone—multiple sclerosis	4.53e-05	0.000178	CcSEcCtD
Tretinoin—Rash—Betamethasone—multiple sclerosis	4.53e-05	0.000178	CcSEcCtD
Tretinoin—Dermatitis—Dexamethasone—multiple sclerosis	4.52e-05	0.000178	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—multiple sclerosis	4.52e-05	0.000178	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.51e-05	0.000177	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—multiple sclerosis	4.5e-05	0.000177	CcSEcCtD
Tretinoin—Headache—Betamethasone—multiple sclerosis	4.5e-05	0.000177	CcSEcCtD
Tretinoin—Headache—Dexamethasone—multiple sclerosis	4.5e-05	0.000177	CcSEcCtD
Tretinoin—Asthenia—Prednisone—multiple sclerosis	4.48e-05	0.000176	CcSEcCtD
Tretinoin—Pain—Methotrexate—multiple sclerosis	4.47e-05	0.000176	CcSEcCtD
Tretinoin—Pruritus—Prednisone—multiple sclerosis	4.42e-05	0.000174	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—SRM—multiple sclerosis	4.42e-05	0.000329	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.38e-05	0.000326	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.38e-05	0.000326	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT3—multiple sclerosis	4.35e-05	0.000324	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.33e-05	0.000322	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.33e-05	0.000322	CbGpPWpGaD
Tretinoin—Feeling abnormal—Methotrexate—multiple sclerosis	4.3e-05	0.000169	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—GPC5—multiple sclerosis	4.29e-05	0.000319	CbGpPWpGaD
Tretinoin—Diarrhoea—Prednisone—multiple sclerosis	4.28e-05	0.000168	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.27e-05	0.000168	CcSEcCtD
Tretinoin—Nausea—Betamethasone—multiple sclerosis	4.26e-05	0.000168	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—multiple sclerosis	4.26e-05	0.000168	CcSEcCtD
Tretinoin—RXRA—Metabolism—CYP27B1—multiple sclerosis	4.25e-05	0.000317	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP24A1—multiple sclerosis	4.25e-05	0.000317	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.16e-05	0.00031	CbGpPWpGaD
Tretinoin—Urticaria—Methotrexate—multiple sclerosis	4.15e-05	0.000163	CcSEcCtD
Tretinoin—Dizziness—Prednisone—multiple sclerosis	4.13e-05	0.000163	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—multiple sclerosis	4.13e-05	0.000162	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—multiple sclerosis	4.13e-05	0.000162	CcSEcCtD
Tretinoin—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.1e-05	0.000305	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—MYC—multiple sclerosis	4.09e-05	0.000305	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—RRM1—multiple sclerosis	4.06e-05	0.000303	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SRM—multiple sclerosis	4.05e-05	0.000302	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TGFB1—multiple sclerosis	4.03e-05	0.000301	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—VDR—multiple sclerosis	3.99e-05	0.000297	CbGpPWpGaD
Tretinoin—Vomiting—Prednisone—multiple sclerosis	3.97e-05	0.000156	CcSEcCtD
Tretinoin—Rash—Prednisone—multiple sclerosis	3.94e-05	0.000155	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—multiple sclerosis	3.94e-05	0.000155	CcSEcCtD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.93e-05	0.000293	CbGpPWpGaD
Tretinoin—Headache—Prednisone—multiple sclerosis	3.92e-05	0.000154	CcSEcCtD
Tretinoin—RXRA—Metabolism—GPC5—multiple sclerosis	3.89e-05	0.00029	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methotrexate—multiple sclerosis	3.85e-05	0.000151	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—TNF—multiple sclerosis	3.77e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—POMC—multiple sclerosis	3.76e-05	0.00028	CbGpPWpGaD
Tretinoin—Asthenia—Methotrexate—multiple sclerosis	3.75e-05	0.000147	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—VDR—multiple sclerosis	3.72e-05	0.000277	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—multiple sclerosis	3.71e-05	0.000146	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—multiple sclerosis	3.7e-05	0.000145	CcSEcCtD
Tretinoin—CRABP2—Metabolism—APOE—multiple sclerosis	3.68e-05	0.000274	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—APOE—multiple sclerosis	3.68e-05	0.000274	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—APOE—multiple sclerosis	3.68e-05	0.000274	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—TGFB1—multiple sclerosis	3.68e-05	0.000274	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—VDR—multiple sclerosis	3.65e-05	0.000272	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PABPC1—multiple sclerosis	3.6e-05	0.000269	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—VDR—multiple sclerosis	3.58e-05	0.000267	CbGpPWpGaD
Tretinoin—Diarrhoea—Methotrexate—multiple sclerosis	3.57e-05	0.000141	CcSEcCtD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.56e-05	0.000266	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.56e-05	0.000266	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—RRM1—multiple sclerosis	3.55e-05	0.000265	CbGpPWpGaD
Tretinoin—Dizziness—Methotrexate—multiple sclerosis	3.45e-05	0.000136	CcSEcCtD
Tretinoin—RARA—Gene Expression—VDR—multiple sclerosis	3.43e-05	0.000256	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—VDR—multiple sclerosis	3.43e-05	0.000256	CbGpPWpGaD
Tretinoin—Vomiting—Methotrexate—multiple sclerosis	3.32e-05	0.000131	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—MYC—multiple sclerosis	3.29e-05	0.000246	CbGpPWpGaD
Tretinoin—Rash—Methotrexate—multiple sclerosis	3.29e-05	0.00013	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—multiple sclerosis	3.29e-05	0.000129	CcSEcCtD
Tretinoin—Headache—Methotrexate—multiple sclerosis	3.27e-05	0.000129	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—SRM—multiple sclerosis	3.27e-05	0.000244	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—RPL5—multiple sclerosis	3.25e-05	0.000242	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—RRM1—multiple sclerosis	3.22e-05	0.00024	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.2e-05	0.000238	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SRM—multiple sclerosis	3.2e-05	0.000238	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—POMC—multiple sclerosis	3.16e-05	0.000235	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—POMC—multiple sclerosis	3.16e-05	0.000235	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—POMC—multiple sclerosis	3.16e-05	0.000235	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.15e-05	0.000235	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.11e-05	0.000232	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.11e-05	0.000232	CbGpPWpGaD
Tretinoin—Nausea—Methotrexate—multiple sclerosis	3.1e-05	0.000122	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—IL6—multiple sclerosis	3.04e-05	0.000227	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.03e-05	0.000226	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SRM—multiple sclerosis	3.02e-05	0.000225	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—MYC—multiple sclerosis	3.01e-05	0.000225	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.97e-05	0.000222	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.97e-05	0.000221	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.96e-05	0.000221	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—MYC—multiple sclerosis	2.96e-05	0.00022	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.91e-05	0.000217	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ALB—multiple sclerosis	2.88e-05	0.000215	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ALB—multiple sclerosis	2.88e-05	0.000215	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ALB—multiple sclerosis	2.88e-05	0.000215	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.85e-05	0.000213	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.85e-05	0.000213	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.85e-05	0.000212	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—MYC—multiple sclerosis	2.83e-05	0.000211	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—MYC—multiple sclerosis	2.83e-05	0.000211	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—POMC—multiple sclerosis	2.8e-05	0.000209	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.77e-05	0.000206	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SRM—multiple sclerosis	2.77e-05	0.000206	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.71e-05	0.000202	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.61e-05	0.000195	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.59e-05	0.000193	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.57e-05	0.000191	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PGR—multiple sclerosis	2.56e-05	0.000191	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.5e-05	0.000186	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.47e-05	0.000184	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.47e-05	0.000184	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.36e-05	0.000176	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—BCHE—multiple sclerosis	2.33e-05	0.000174	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.3e-05	0.000172	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.3e-05	0.000172	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SRM—multiple sclerosis	2.25e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.25e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.25e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.16e-05	0.000161	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.15e-05	0.00016	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TYK2—multiple sclerosis	2.14e-05	0.000159	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.13e-05	0.000159	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.13e-05	0.000159	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.11e-05	0.000157	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.09e-05	0.000156	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.08e-05	0.000155	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.06e-05	0.000153	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—BCHE—multiple sclerosis	2.04e-05	0.000152	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—MYC—multiple sclerosis	1.97e-05	0.000147	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.96e-05	0.000146	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.95e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.95e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPC5—multiple sclerosis	1.95e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.91e-05	0.000142	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.86e-05	0.000139	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—BCHE—multiple sclerosis	1.85e-05	0.000138	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—VDR—multiple sclerosis	1.79e-05	0.000133	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.78e-05	0.000133	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.75e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.000127	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP9—multiple sclerosis	1.68e-05	0.000125	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.61e-05	0.00012	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.59e-05	0.000118	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.59e-05	0.000118	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—multiple sclerosis	1.59e-05	0.000118	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.55e-05	0.000116	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—STAT3—multiple sclerosis	1.5e-05	0.000111	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SRM—multiple sclerosis	1.49e-05	0.000111	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.48e-05	0.00011	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—multiple sclerosis	1.48e-05	0.00011	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.45e-05	0.000108	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—multiple sclerosis	1.45e-05	0.000108	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—multiple sclerosis	1.42e-05	0.000106	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—APOE—multiple sclerosis	1.4e-05	0.000105	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TGFB1—multiple sclerosis	1.39e-05	0.000103	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.38e-05	0.000103	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—multiple sclerosis	1.36e-05	0.000102	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—multiple sclerosis	1.36e-05	0.000102	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MAPK1—multiple sclerosis	1.36e-05	0.000101	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000101	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—multiple sclerosis	1.29e-05	9.65e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	9.32e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.24e-05	9.26e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—APOE—multiple sclerosis	1.23e-05	9.14e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—POMC—multiple sclerosis	1.21e-05	8.99e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.2e-05	8.96e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.15e-05	8.54e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—APOE—multiple sclerosis	1.11e-05	8.3e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—multiple sclerosis	1.1e-05	8.19e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.07e-05	8.01e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—POMC—multiple sclerosis	1.05e-05	7.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.05e-05	7.8e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.05e-05	7.8e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—multiple sclerosis	1.04e-05	7.79e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BCHE—multiple sclerosis	1e-05	7.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.85e-06	7.34e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—BCHE—multiple sclerosis	9.8e-06	7.3e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.8e-06	7.3e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—multiple sclerosis	9.61e-06	7.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.57e-06	7.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—multiple sclerosis	9.56e-06	7.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.33e-06	6.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—BCHE—multiple sclerosis	9.26e-06	6.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.98e-06	6.69e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—multiple sclerosis	8.72e-06	6.5e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BCHE—multiple sclerosis	8.49e-06	6.33e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—multiple sclerosis	8.16e-06	6.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.02e-06	5.97e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.93e-06	5.91e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—multiple sclerosis	7.48e-06	5.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.31e-06	5.45e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—multiple sclerosis	7.11e-06	5.3e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—multiple sclerosis	7.01e-06	5.22e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.91e-06	5.15e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—multiple sclerosis	6.42e-06	4.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—multiple sclerosis	6.39e-06	4.76e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—multiple sclerosis	6.03e-06	4.49e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—multiple sclerosis	5.9e-06	4.39e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—multiple sclerosis	5.86e-06	4.36e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—multiple sclerosis	5.57e-06	4.15e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—multiple sclerosis	5.18e-06	3.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—multiple sclerosis	5.11e-06	3.81e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—multiple sclerosis	5.06e-06	3.77e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—multiple sclerosis	4.78e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—multiple sclerosis	4.72e-06	3.52e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—multiple sclerosis	4.62e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.56e-06	3.4e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—multiple sclerosis	4.39e-06	3.27e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—multiple sclerosis	4.36e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—multiple sclerosis	4.16e-06	3.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—multiple sclerosis	4e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—multiple sclerosis	3.57e-06	2.66e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—multiple sclerosis	3.26e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—multiple sclerosis	2.74e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—multiple sclerosis	2.35e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—multiple sclerosis	2.15e-06	1.6e-05	CbGpPWpGaD
